Therapeutic efficacy of humanized monoclonal antibodies targeting dengue virus nonstructural protein 1 in the mouse model.
Dengue virus (DENV) which infects about 390 million people per year in tropical and subtropical areas manifests various disease symptoms, ranging from fever to life-threatening hemorrhage and even shock. To date, there is still no effective treatment for DENV disease, but only supportive care. DENV...
Main Authors: | Sen-Mao Tien, Po-Chun Chang, Yen-Chung Lai, Yung-Chun Chuang, Chin-Kai Tseng, Yu-San Kao, Hong-Jyun Huang, Yu-Peng Hsiao, Yi-Ling Liu, Hsing-Han Lin, Chien-Chou Chu, Miao-Huei Cheng, Tzong-Shiann Ho, Chih-Peng Chang, Shu-Fen Ko, Che-Piao Shen, Robert Anderson, Yee-Shin Lin, Shu-Wen Wan, Trai-Ming Yeh |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-04-01
|
Series: | PLoS Pathogens |
Online Access: | https://doi.org/10.1371/journal.ppat.1010469 |
Similar Items
-
Dengue Nonstructural Protein 1 Maintains Autophagy through Retarding Caspase-Mediated Cleavage of Beclin-1
by: Zi-Yi Lu, et al.
Published: (2020-12-01) -
Negative regulation of type I interferon signaling by integrin-linked kinase permits dengue virus replication.
by: Yi-Sheng Kao, et al.
Published: (2023-03-01) -
RECOMBINANT MONOCLONAL ANTIBODIES FOR NEUROSCIENCE RESEARCH
by: Alexander Ball, et al.
Published: (2023-10-01) -
Nonstructural barriers to adult vaccination
by: T. Mark Doherty, et al.
Published: (2024-12-01) -
Abnormal Activity Detection and Classification of Bus Passengers With In-Vehicle Image Sensing
by: Huei-Yung Lin, et al.
Published: (2024-01-01)